Viewing Study NCT06806657

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2026-02-10 @ 9:15 AM
Study NCT ID: NCT06806657
Status: RECRUITING
Last Update Posted: 2025-08-29
First Post: 2025-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab
Sponsor: CSL Behring
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hereditary Angioedema View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Autosomal dominant disease View
None Hereditary angioedema attack View
None Monoclonal antibody View